IONS
Ionis Pharmaceuticals Inc
43.50$
-1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | +487.4% | -151.1% | – | – | – | +3,284.5% | -90.1% | +236.1% | -630.7% | – | +246.2% | -42.7% | -89.6% | -14.2% | -990.8% | – | – | – | |
| – | +23.1% | +34.4% | +20.9% | +6.4% | +25.9% | +47.9% | +18.9% | -0.7% | -20.4% | -25.5% | -6.3% | +0.8% | +66.2% | -19.0% | +28.4% | -8.7% | -9.0% | -3.9% | +8.9% | -11.8% | -7.6% | +50.1% | +27.7% | +7.3% | +14.0% | +13.0% | +1.8% | -12.6% | +15.5% | |
| – | – | – | – | – | – | -165.6% | – | – | -159.6% | – | +72.4% | +52.0% | -11.1% | -9.2% | -19.0% | -12.9% | +33.2% | +174.9% | +89.0% | +21.6% | +19.2% | +52.7% | +11.6% | +57.0% | -47.6% | -16.9% | +5.5% | +23.1% | +2.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -32.6% | -138.1% | – | -25.9% | +775.8% | +28.1% | +9.7% | -285.2% | – | +227.7% | -75.2% | -21.3% | – | – | – | |
| – | +146.4% | -207.2% | – | – | – | -171.7% | – | – | – | – | +1,970.3% | +293.4% | -149.4% | – | – | – | +71.3% | -93.9% | +294.7% | -836.6% | – | +1,046.6% | -133.8% | – | – | – | -1,120.5% | – | – | |
| – | +288.9% | +25.7% | +9.1% | -65.6% | +463.2% | +296.6% | -79.5% | -53.3% | -88.0% | +505.7% | +96.0% | +240.7% | -4.5% | +7.7% | -37.4% | -53.0% | +3.7% | +107.1% | +5.8% | -1.9% | +228.4% | -53.4% | +105.5% | +13.1% | -56.4% | +12.3% | +39.4% | +61.7% | +13.6% | |
| – | +34.5% | – | -186.8% | +1,107.3% | +50.4% | -57.9% | -75.0% | – | -99.4% | -6,138.7% | +70.6% | +321.0% | -9.4% | – | +368.0% | -83.8% | -1,520.8% | -67.6% | -27.5% | – | -733.0% | +159.4% | -95.6% | – | -29.0% | -234.8% | -18.5% | -37.4% | +107.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -34.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -18.1% | +165.5% | +2,394.7% | -90.2% | +7.9% | -49.4% | +1,908.6% | +88.0% | -107.2% | +163.3% | -81.5% | -34.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +34.7% | – | -153.7% | – | -101.6% | +449.5% | – | +72.7% | -122.8% | – | +33.4% | -112.1% | – | -151.4% | – | |
| – | +59.6% | -58.9% | +323.2% | +92.3% | +92.9% | -45.3% | -67.7% | -71.0% | +209.4% | +297.5% | -70.8% | +146.5% | +87.8% | -97.7% | -114.3% | – | +482.0% | -73.8% | -58.5% | -53.9% | +1,910.6% | +107.7% | -79.0% | -696.5% | – | -122.5% | – | -25.8% | +41.4% | |
| – | +59.6% | -58.9% | -49.0% | -43.9% | +1,923.5% | -128.8% | – | – | – | – | -62.1% | +254.2% | -239.1% | – | – | – | -39.9% | -147.8% | – | – | – | +231.9% | +171.1% | -170.6% | – | -225.7% | – | -228.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +527.2% | -164.0% | – | – | – | – | -108.3% | – | -1,418.5% | – | +329.4% | -47.1% | -101.7% | – | -2,383.1% | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.